DocWire News Editors

DocwireNews

There exist unique challenges with respect to managing and treating the elderly with cancer, and functional age, determined by geriatric assessment (GA) can influence treatment related effects and health outcomes, according to research presented at the 2019 HOPA Annual Conference by Ginah Nightingale, PharmD, BCOP, Associate Professor of the Department of Pharmacy Practice Jefferson College of Pharmacy, Thomas Jefferson University.
Most cancer diagnoses and deaths occur in older adults, which is important to note considering that by the year 2050 most counties across Europe and Asia “will have 30% of their population comprised of older adults.” However, chronological age does always equal functional age. The true hallmark of aging occurs due to reduced physiologic reserves. This “fuel available” is not always apparent when a person is at rest, and usually becomes more obvious with the involvement of a stressor.
A factor other than chronological age that predicts both morbidity and mortality for seniors with cancer is geriatric assessment (GA), and key domains for GA assessment (and how they influence treatment) include:
<ul>
<li>Functional Status – If the patient is unable to manager and administer their medications independently, they incur an increased risk of medication errors.</li>
<li>Comorbidity – If the elderly patient has multiple comorbidities, they stand an increased chance of their cancer therapies exacerbating their chronic conditions.</li>
<li>Cognition – Patients with a lower baseline cognitive reserve have an augmented risk of further cognitive deterioration when treated by certain medications (e.g. anti-androgen therapy).</li>
<li>Nutrition – Any elderly patient that is unable to manage their nutrition or is malnourished stands an increased risk of medication errors.</li>
<li>Psychological State &amp; Social Support – Social isolation is associated with increased chemotherapy toxicity, and if that patient lacks reliable caregiver support, decision making, treatment/lab tests, and management of complex therapies can be affected.</li>
<li>Polypharmacy – This GA component can affect the patient if they are taking several medications, or a potentially inappropriate medication.</li>
</ul>
Dr. Nightengale noted in a presentation slide that “using GA to evaluate patients beyond chronologic age and/or age-related physiologic organ impairment provides a complementary and robust characterization of an older adult’s fitness for cancer therapy.”
While few studies have incorporated GA assessments into cancer trial methodology, the presenter indicated on a concluding slide that “broadening cancer therapy trials to capture not only chronological age but functional age would allow clinicians to better identify subsets of older adults who are most vulnerable to morbidity and mortality.”

Emily Menendez

Complete Response to Immunotherapy in HCC: Insights From IMbrave150

Hepatocellular Carcinoma

Anne Marie Morse, DO

Rob Dillard

Dr. Morse Talks About the Significance of World Sleep Day 2025

Sleep Disorders

Dr. John Fruehauf, Evolent

Advancing Therapies Have Improved the Prognosis of Metastatic Melanoma

Melanoma

Latest News

Are “Silver Survivors” Too Old for Treatment? How Chronologic and Functional Age Can Influence Treatment-related Effects

2019 HOPA Annual Conference

There exist unique challenges with respect to managing and treating the elderly with cancer, and functional age, determined by geriatric assessment

Are “Silver Survivors” Too Old for Treatment? How Chronologic and Functional Age Can Influence

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe